Analysts predict potential stock upside for Soleno Therapeutics based on price targets and positive earnings estimate revisions.
2 reports, 1 independent
Updated Aug 11
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Analysts predict potential stock upside for Soleno Therapeutics based on price targets and positive earnings estimate revisions.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Coverage
Newest first; wire copies grouped- ZacksHow Much Upside is Left in Soleno Therapeutics (SLNO)? Wall Street Analysts Think 43.15% Shares of Soleno Therapeutics, Inc. (SLNO) have gained 1% over the past four weeks to close the last trading s
- ZacksCan Soleno Therapeutics (SLNO) Climb 33.11% to Reach the Level Wall Street Analysts Expect? Shares of Soleno Therapeutics, Inc. (SLNO) have gained 2.2% over the past four weeks to close the last trad